The involvement of PRL3 results in the phosphorylation of FAK which then activates the p38 and PI3K/AKT pathway, mediating the oncogenic effect of PRL3 in HCC cells 14. This evidence concerns the gene PTP4A3 and hepatocellular carcinoma.